{"id":"doi:10.1210/clinem/dgab578","kind":"review","title":"The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD","authors":["Chandani Patel Chavez","Kenneth J. Cusi","Sushma Kadiyala"],"author_count":3,"year":2021,"published":"2021-08-18","venue":"The Journal of Clinical Endocrinology & Metabolism","cited_by":163,"doi":"10.1210/clinem/dgab578","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1210/clinem/dgab578","archive_url":"https://space-kitty.com/papers/doi:10.1210/clinem/dgab578","updated":null,"pmid":"34406410","pmcid":null,"openalex_id":"W3193656600","pdf_url":"https://academic.oup.com/jcem/article-pdf/107/1/29/41819405/dgab578.pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Liver Disease Diagnosis and Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}